| 2021-03-02 | Sale | Stoke Therapeutics, Inc. STOK | EVP Research & Preclinical Dev | 5,195 0.0149% | $63.05 | $327,546 | -55.58% | |
| 2020-12-28 | Sale | Stoke Therapeutics, Inc. STOK | EVP Research & Preclinical Dev | 149 0.0004% | $58.73 | $8,751 | -46.44% | |
| 2020-10-19 | Sale | Stoke Therapeutics, Inc. STOK | EVP Research & Preclinical Dev | 32,000 0.097% | $37.82 | $1.21M | +0.68% | |
| 2020-10-16 | Sale | Stoke Therapeutics, Inc. STOK | EVP Research & Preclinical Dev | 5,851 0.0179% | $40.00 | $234,042 | -3.87% | |
| 2020-10-13 | Sale | Stoke Therapeutics, Inc. STOK | EVP Research & Preclinical Dev | 1,649 0.0051% | $40.00 | $65,960 | -2.69% | |
| 2020-06-01 | Sale | Stoke Therapeutics, Inc. STOK | EVP Research & Preclinical Dev | 20,000 0.0626% | $26.35 | $527,037 | +47.31% | |
| 2020-05-22 | Sale | Stoke Therapeutics, Inc. STOK | EVP Research & Preclinical Dev | 15,000 0.0234% | $15.30 | $229,500 | +21.56% |